Stocktoria

SkinHealth Systems Inc. SKIN

Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2020-02-10
Chart by TradingView
6/9
Piotroski F — financial health
-1.89
Altman Z″ — distress risk · distress
Dividend payout · no dividend

Financials & ratios (annual, from 10-K)

MetricFY2025FY2024FY2023FY2022FY2021
Financials
Revenue$300.8M$334.3M$398.0M$365.9M$260.1M
Gross profit$196.4M$182.3M$155.1M$248.8M$178.5M
Operating income-$20.8M-$67.8M-$130.9M-$25.8M-$39.9M
Net income-$9.5M-$29.1M-$100.1M$44.2M-$378.8M
Operating cash flow$37.5M$16.1M$21.8M-$106.6M-$28.4M
Free cash flow$37.2M$15.4M$17.9M-$117.4M-$39.6M
Total assets$499.8M$685.7M$929.1M$1.0B$1.2B
Total liabilities$438.7M$633.9M$869.7M$836.0M$916.5M
Shareholders' equity$61.1M$51.8M$59.4M$167.1M$298.0M
Ratios
Gross margin65.3%54.5%39.0%68.0%68.6%
Operating margin-6.9%-20.3%-32.9%-7.1%-15.4%
Net margin-3.2%-8.7%-25.2%12.1%-145.6%
FCF margin12.4%4.6%4.5%-32.1%-15.2%
Return on assets-1.9%-4.2%-10.8%4.4%-31.1%
Return on equity-15.6%-56.2%-168.6%26.5%-127.1%
Debt / equity10.66×
Current ratio1.667.006.0710.9213.09
Revenue growth-10.0%-16.0%8.8%40.7%118.4%

Notable holders (13F)

InvestorSharesValue
RENAISSANCE TECHNOLOGIES LLC283,791$252,574

Why these scores methodology →

Piotroski F-score: 6/9

  • Positive return on assets
  • Positive operating cash flow
  • Rising ROA
  • Cash flow exceeds net income
  • Lower long-term debt
  • Rising current ratio
  • No share dilution
  • Rising gross margin
  • Rising asset turnover

Altman Z″: -1.89 (distress)

  • Working capital / assets 0.247
  • Retained earnings / assets -1.035
  • EBIT / assets -0.042
  • Equity / liabilities 0.139

Sector peers

VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →

Source: SEC EDGAR filings · CIK 0001818093 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.